We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure coreplatform@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
Epilepsy affects approximately 1% of the population [1]. Although generally treatable, up to 30% of patients do not achieve seizure freedom from anticonvulsive medication alone. Due to its relationship with cognitive abilities [2], quality of life [3], and the associated risk of premature death [4], drug-refractory epilepsy should be treated promptly. Temporal lobe epilepsy (TLE) associated with mesiotemporal sclerosis [5] and extra-temporal lobe epilepsy related to focal cortical dysplasia (FCD) [6] constitute the most common refractory epilepsy syndromes. Surgical resection of these lesions remains the treatment of choice [7], with success rates approaching 80% [8]. By allowing the detection of epileptogenic lesions and offering system-level mechanisms of the disease process, MRI has shifted the field from electro-clinical correlations toward a multidisciplinary approach.
Epilepsy is a prevalent and serious neurological disorder. This vital textbook addresses the role of neuroimaging as a unique tool to provide in vivo biomarkers aimed at furthering our understanding of causes and consequences of epilepsy in a day-to-day clinical context. Unique in its approach, this translational book presents a critical appraisal of advanced pre-clinical biomarkers that allows capturing epileptogenesis at molecular, cellular, and neuronal system levels. The book is divided into four sections. Part I includes a series of chapters focused on imaging of early disease stages. Part II discusses lesion detection and network analysis methods. Part III focuses on imaging methods used to predict response to antiepileptic drugs and surgery. Finally, Part IV presents imaging techniques used to evaluate disease consequence.